Neuronetics (STIM) Shares Outstanding (Diluted Average) (2019 - 2025)
Neuronetics (STIM) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $67.3 million as the latest value for Q3 2025.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 122.38% to $67.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $67.3 million, a 122.38% increase, with the full-year FY2024 number at $31.7 million, up 10.73% from a year prior.
- Shares Outstanding (Diluted Average) was $67.3 million for Q3 2025 at Neuronetics, up from $66.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $67.3 million in Q3 2025 to a low of $25.2 million in Q1 2021.
- A 5-year average of $33.7 million and a median of $28.6 million in 2023 define the central range for Shares Outstanding (Diluted Average).
- Peak YoY movement for Shares Outstanding (Diluted Average): increased 1.89% in 2022, then skyrocketed 122.38% in 2025.
- Neuronetics' Shares Outstanding (Diluted Average) stood at $25.5 million in 2021, then grew by 5.58% to $26.9 million in 2022, then grew by 6.54% to $28.7 million in 2023, then grew by 10.73% to $31.7 million in 2024, then skyrocketed by 112.1% to $67.3 million in 2025.
- Per Business Quant, the three most recent readings for STIM's Shares Outstanding (Diluted Average) are $67.3 million (Q3 2025), $66.2 million (Q2 2025), and $61.5 million (Q1 2025).